Renishaw Stock Rating Lowered by Investec (RSW)
Renishaw (LON:RSW) was downgraded by research analysts at Investec to a “sell” rating in a report released on Monday, AnalystRatings.Net reports. They currently have a GBX 1,695 ($27.93) target price on the stock, up from their previous target price of GBX 1,670 ($27.52). Investec’s price objective suggests a potential downside of 13.48% from the company’s current price.
A number of other analysts have also recently weighed in on RSW. Analysts at Credit Suisse reiterated a “neutral” rating on shares of Renishaw in a research note to investors on Thursday, December 12th. They now have a GBX 1,715 ($28.26) price target on the stock. Separately, analysts at Nplus1 Brewin downgraded shares of Renishaw to a “hold” rating in a research note to investors on Monday, October 21st. They now have a GBX 1,675 ($27.60) price target on the stock. Finally, analysts at N+1 Singer reiterated a “hold” rating on shares of Renishaw in a research note to investors on Monday, October 21st. They now have a GBX 1,675 ($27.60) price target on the stock. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of GBX 1,741.79 ($28.70).
Shares of Renishaw (LON:RSW) opened at 1939.00 on Monday. Renishaw has a one year low of GBX 1444.00 and a one year high of GBX 2124.00. The stock’s 50-day moving average is GBX 1886. and its 200-day moving average is GBX 1734.31. The company’s market cap is £1.411 billion.
Renishaw plc is engaged in the design, manufacture and sale of advanced precision metrology and inspection equipment together with products for the healthcare sector, including Raman spectroscopy systems, dental systems, molecular diagnostic equipment and neurosurgical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.